Literature DB >> 8394378

Development of a rapid and efficient restriction endonuclease analysis typing system for Clostridium difficile and correlation with other typing systems.

C R Clabots1, S Johnson, K M Bettin, P A Mathie, M E Mulligan, D R Schaberg, L R Peterson, D N Gerding.   

Abstract

A HindIII restriction endonuclease analysis (REA) typing system for total genomic Clostridium difficile DNA including a rapid and efficient method of DNA extraction and a scheme for organizing unique electrophoretic DNA band patterns was developed. REA typing was performed by two extraction methods for 1,965 C. difficile isolates obtained from patients with symptomatic C. difficile disease, asymptomatic patients who were C. difficile culture positive, and environmental surfaces. This isolate collection yielded 206 unique REA types, which were organized into 75 groups. A reference strain representing each unique REA type was chosen for DNA band pattern comparisons, cytotoxin testing, and plasmid analysis. The DNA band patterns utilizing a guanidine thiocyanate-EDTA-Sarkosyl DNA extraction method were 94% reproducible, while the original and sporadically problematic diethyl pyrocarbonate-sodium dodecyl sulfate DNA extraction method was 98% reproducible when readable patterns were obtained. Reference strains from 43 of the 75 groups were cytotoxin positive, 28 groups were cytotoxin negative, and 4 groups included both toxigenic and nontoxigenic strains. Cytotoxicity of isolates with a particular REA type was always consistent with the toxicity of the reference strain for that type. REA typing was able to discriminate strain differences within types identified by the immunoblot (89 isolates), bacteriophage-bacteriocin (44 isolates), and ribotyping (23 isolates) methods. REA typing is a sensitive, discriminating, reproducible, and rapid method for differentiating C. difficile strains and is suitable for large-scale epidemiologic studies.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8394378      PMCID: PMC265648          DOI: 10.1128/jcm.31.7.1870-1875.1993

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  26 in total

1.  Application of whole-cell DNA restriction endonuclease profiles to the epidemiology of Clostridium difficile-induced diarrhea.

Authors:  E J Kuijper; J H Oudbier; W N Stuifbergen; A Jansz; H C Zanen
Journal:  J Clin Microbiol       Date:  1987-04       Impact factor: 5.948

2.  Evoked potentials: computer-automated threshold-tracking procedure using an objective detection criterion.

Authors:  R J Salvi; W Ahroon; S S Saunders; S A Arnold
Journal:  Ear Hear       Date:  1987-06       Impact factor: 3.570

3.  Clostridium difficile-associated diarrhea and colitis in adults. A prospective case-controlled epidemiologic study.

Authors:  D N Gerding; M M Olson; L R Peterson; D G Teasley; R L Gebhard; M L Schwartz; J T Lee
Journal:  Arch Intern Med       Date:  1986-01

4.  Role of DNase in recovery of plasmid DNA from Clostridium perfringens.

Authors:  H P Blaschek; M A Klacik
Journal:  Appl Environ Microbiol       Date:  1984-07       Impact factor: 4.792

5.  Bacteriophage and bacteriocin typing scheme for Clostridium difficile.

Authors:  T L Sell; D R Schaberg; F R Fekety
Journal:  J Clin Microbiol       Date:  1983-06       Impact factor: 5.948

6.  Typing scheme for Clostridium difficile: its application in clinical and epidemiological studies.

Authors:  S Tabaqchali; D Holland; S O'Farrell; R Silman
Journal:  Lancet       Date:  1984-04-28       Impact factor: 79.321

7.  Detection of Clostridium difficile toxins A (enterotoxin) and B (cytotoxin) in clinical specimens. Evaluation of a latex agglutination test.

Authors:  L R Peterson; J J Holter; C J Shanholtzer; C R Garrett; D N Gerding
Journal:  Am J Clin Pathol       Date:  1986-08       Impact factor: 2.493

8.  Acquisition of Clostridium difficile by hospitalized patients: evidence for colonized new admissions as a source of infection.

Authors:  C R Clabots; S Johnson; M M Olson; L R Peterson; D N Gerding
Journal:  J Infect Dis       Date:  1992-09       Impact factor: 5.226

9.  Selective and differential medium for isolation of Clostridium difficile.

Authors:  W L George; V L Sutter; D Citron; S M Finegold
Journal:  J Clin Microbiol       Date:  1979-02       Impact factor: 5.948

10.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

View more
  58 in total

1.  Comparison of an automated ribotyping system to restriction endonuclease analysis and pulsed-field gel electrophoresis for differentiating vancomycin-resistant Enterococcus faecium isolates.

Authors:  Connie S Price; Holly Huynh; Suzanne Paule; Richard J Hollis; Gary A Noskin; Michael A Pfaller; Lance R Peterson
Journal:  J Clin Microbiol       Date:  2002-05       Impact factor: 5.948

2.  Contamination of the clinical microbiology laboratory with vancomycin-resistant enterococci and multidrug- resistant Enterobacteriaceae: implications for hospital and laboratory workers.

Authors:  S M Collins; D M Hacek; L A Degen; M O Wright; G A Noskin; L R Peterson
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

3.  Differences in the Molecular Epidemiology and Antibiotic Susceptibility of Clostridium difficile Isolates in Pediatric and Adult Patients.

Authors:  Larry K Kociolek; Dale N Gerding; James R Osmolski; Sameer J Patel; David R Snydman; Laura A McDermott; David W Hecht
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

4.  Toxin gene analysis of a variant strain of Clostridium difficile that causes human clinical disease.

Authors:  S P Sambol; M M Merrigan; D Lyerly; D N Gerding; S Johnson
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

5.  Comparative phylogenomics of Clostridium difficile reveals clade specificity and microevolution of hypervirulent strains.

Authors:  R A Stabler; D N Gerding; J G Songer; D Drudy; J S Brazier; H T Trinh; A A Witney; J Hinds; B W Wren
Journal:  J Bacteriol       Date:  2006-10       Impact factor: 3.490

6.  Comparative genomics analysis of Clostridium difficile epidemic strain DH/NAP11/106.

Authors:  Larry K Kociolek; Dale N Gerding; David W Hecht; Egon A Ozer
Journal:  Microbes Infect       Date:  2018-01-31       Impact factor: 2.700

7.  Multilocus variable-number tandem-repeat analysis and multilocus sequence typing reveal genetic relationships among Clostridium difficile isolates genotyped by restriction endonuclease analysis.

Authors:  Jane W Marsh; Mary M O'Leary; Kathleen A Shutt; Susan P Sambol; Stuart Johnson; Dale N Gerding; Lee H Harrison
Journal:  J Clin Microbiol       Date:  2009-12-02       Impact factor: 5.948

8.  Relapses or reinfections: analysis of a case of Clostridium difficile-associated colitis by two typing systems.

Authors:  H Kato; N Kato; K Watanabe; K Ueno; Y Sakata; K Fujita
Journal:  Curr Microbiol       Date:  1996-10       Impact factor: 2.188

9.  PCR ribotyping and arbitrarily primed PCR for typing strains of Clostridium difficile from a Polish maternity hospital.

Authors:  G Martirosian; S Kuipers; H Verbrugh; A van Belkum; F Meisel-Mikolajczyk
Journal:  J Clin Microbiol       Date:  1995-08       Impact factor: 5.948

10.  Asymptomatic carriage of Clostridium difficile in an Irish continuing care institution for the elderly: prevalence and characteristics.

Authors:  J Ryan; C Murphy; C Twomey; R Paul Ross; M C Rea; J MacSharry; B Sheil; F Shanahan
Journal:  Ir J Med Sci       Date:  2009-06-04       Impact factor: 1.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.